Aynechi Tiba
SEC insider (Form 3/4/5 filer). CIK 0001669220. Director at MBX Biosciences, Inc. (MBX) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in CARMEL, IN.
Companies Aynechi Tiba has filed insider reports for
- MBX Biosciences, Inc. (MBX): Director
- SPRUCE BIOSCIENCES, INC. (SPRB): Director
Aynechi Tiba
CIK: 0001669220
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 4, 2026MBX
MBX Biosciences, Inc.
AwardDirectStock option (right to buy)
12.5K shares- - Jul 22, 2025SPRB
SPRUCE BIOSCIENCES, INC.
AwardDirectStock Option (Right to Buy)
30K shares- - Jun 5, 2025MBX
MBX Biosciences, Inc.
AwardDirectStock option (right to buy)
16K shares- - Sep 16, 2024MBX
MBX Biosciences, Inc.
ConversionIndirect1.4M shares- - Sep 16, 2024MBX
MBX Biosciences, Inc.
PurchaseIndirect750K shares at avg. $16.00$12.0M - Sep 12, 2024MBX
MBX Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
16K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  MBX MBX Biosciences, Inc. | Award Stock option (right to buy) | 12,500 | - | - | Direct |
| Jul 22, 2025 |  SPRB SPRUCE BIOSCIENCES, INC. | Award Stock Option (Right to Buy) | 30,000 | - | - | Direct |
| Jun 5, 2025 | MBX MBX Biosciences, Inc. | Award Stock option (right to buy) | 16,000 | - | - | Direct |
| Sep 16, 2024 | MBX MBX Biosciences, Inc. | Conversion | 1,386,335 | - | $0 | Indirect |
| Sep 16, 2024 | MBX MBX Biosciences, Inc. | Purchase | 750,000 | $16.00 | $12,000,000 | Indirect |
| Sep 12, 2024 | MBX MBX Biosciences, Inc. | Award Stock Option (Right to Buy) | 15,963 | - | - | Direct |
1-6 of 6 transactions